Generating real-world external comparators (rwECs) for randomized clinical trials (RCTs) in metastatic breast cancer (mBC) using electronic health records (EHRs) Published December 2021 Citation Amiri-Kordestani, L, Gao, X, Baxi, SS, Bloomquist, E, Bryan, J, Howie, L, Keane, C, Kluetz, P, Osgood, C, Paliwal, P, Rivera, DR, Roose, JP, Schneider, J, Ssingh, H, Tang, S, Zhang, L, Beaver, J. . SABCS. . https://www.sabcs.org/Program/Poster-Sessions/Poster-Session-2 Authors:Amiri-Kordestani, L, Gao, X, Baxi, SS, Bloomquist, E, Bryan, J, Howie, L, Keane, C, Kluetz, P, Osgood, C, Paliwal, P, Rivera, DR, Roose, JP, Schneider, J, Ssingh, H, Tang, S, Zhang, L, Beaver, J Sources:San Antonio Breast Cancer Symposium Share Posted inPublicationsMethodologyComparative effectivenessMetastatic breast cancer More publicationsESMO OpenSeptember 2025Real-world progression-free survival of CDK4/6 inhibitors plus an aromatase inhibitor in HR-positive/HER2-negative metastatic breast cancer in United States routine clinical practiceRugo H, Layman R, Lynce F, et al.Publication summaryPublicationsComparative effectivenessMetastatic breast cancerBreast cancerESMO OpenJanuary 2025Comparative overall survival of CDK4/6 inhibitors plus an aromatase inhibitor in HR+/HER2− metastatic breast cancer in the US real-world settingRugo H.S., Layman R.M., Lynce F, et al. Real-world evidencePublication summaryPublicationsComparative effectivenessMetastatic breast cancerISPOR EuropeOctober 2025Assessing bias in LLM-extracted real-world data: A health equity analysis of access to care and outcomes in metastatic breast cancerMbah O, Ho G, Keane C, Yuan Q, Ryals C.Publication summaryPublicationsMetastatic breast cancer